Shandong Xinhua Pharmaceutical Company Limited (HKG:0719)

HKG:0719 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 20, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Market Capitalization	10,637	9,282	11,897	17,740	6,846	5,447
Market Cap Growth	9.99%	-21.98%	-32.94%	159.15%	25.67%	25.64%
Enterprise Value	11,215	10,083	12,706	17,708	8,175	6,459
Last Close Price	6.90	5.57	5.23	7.09	3.95	2.88
PE Ratio	11.48	18.56	21.75	38.17	16.00	14.12
PS Ratio	1.15	1.03	1.33	2.09	0.85	0.76
PB Ratio	1.81	1.67	2.26	3.61	1.53	1.35
P/TBV Ratio	2.12	1.97	2.66	4.30	1.86	1.65
P/FCF Ratio	36.19	56.20	-	30.56	563.90	32.76
P/OCF Ratio	22.36	23.73	40.71	20.70	21.52	10.92
EV/Sales Ratio	1.21	1.12	1.42	2.09	1.01	0.91
EV/EBITDA Ratio	10.28	9.03	11.24	16.45	7.93	6.45
EV/EBIT Ratio	23.40	18.56	22.52	33.62	16.50	11.86
EV/FCF Ratio	38.15	61.05	-	30.51	673.39	38.85
Debt / Equity Ratio	0.28	0.32	0.28	0.32	0.45	0.49
Debt / EBITDA Ratio	1.52	1.58	1.32	1.45	1.95	1.95
Debt / FCF Ratio	5.66	10.74	-	2.70	166.46	11.75
Asset Turnover	0.95	0.98	0.98	0.96	0.91	0.89
Inventory Turnover	5.40	5.01	4.58	4.93	4.48	3.77
Quick Ratio	0.85	0.85	0.76	0.68	0.65	0.59
Current Ratio	1.31	1.33	1.33	1.09	1.10	1.13
Return on Equity (ROE)	7.59%	9.74%	11.09%	10.65%	10.28%	10.68%
Return on Assets (ROA)	3.06%	3.69%	3.87%	3.73%	3.50%	4.24%
Return on Invested Capital (ROIC)	6.97%	8.58%	9.94%	9.22%	7.95%	9.52%
Return on Capital Employed (ROCE)	7.20%	8.20%	8.80%	9.10%	8.40%	9.70%
Earnings Yield	3.93%	5.39%	4.60%	2.62%	6.25%	7.08%
FCF Yield	2.76%	1.78%	-0.55%	3.27%	0.18%	3.05%
Dividend Yield	4.35%	5.26%	5.27%	3.19%	4.66%	6.19%
Payout Ratio	55.78%	48.05%	35.43%	39.66%	42.59%	39.05%
Buyback Yield / Dilution	0.13%	0.54%	-3.20%	-6.93%	0.02%	-0.86%
Total Shareholder Return	4.51%	5.80%	2.07%	-3.74%	4.68%	5.33%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.